Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Clinical nutrition

A randomized controlled trial to determining the effect of cinnamon on the plasma levels of soluble forms of vascular adhesion molecules in type 2 diabetes mellitus

European Journal of Clinical Nutrition volume 73, pages 1605–1612 (2019)Cite this article

Subjects

Abstract

Soluble forms of vascular adhesion molecules, ICAM-1 and VCAM-1, accelerate atherosclerosis pathogenesis. The present study was conducted to evaluate the effect of daily supplementation of 3 g cinnamon on the plasma levels of ICAM-1 and VCAM-1 among patients with type 2 diabetes. This randomized double-blind placebo-controlled trial was performed on 44 adult patients with type 2 diabetes aged 25–70 years. The patients were randomized to two groups of intervention (n = 22) and control (n = 22), differing by daily cinnamon supplementation or placebo (3 g) for 8 weeks. Plasma levels of ICAM-1 and VCAM-1 were measured at the beginning and end of the study. After 8 weeks, 39 subjects (n = 20 in the cinnamon and n = 19 in the placebo groups) completed the trial. There was a significant reduction in the mean levels of ICAM-1 and VCAM-1 within cinnamon and placebo groups (P < 0.001). But there was no significant difference in ICAM-1 (P = 0.75) and VCAM-1 (P = 0.72) between the groups at the end of the trial. According to the results, cinnamon supplementation has no beneficial effect on the reduction of ICAM-1 and VCAM-1 levels in patients with type 2 diabetes, which have a role in the development of atherogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The dataset supporting the findings of this article is available upon request from the corresponding author.

References

  1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49.

    Article  CAS  Google Scholar 

  2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.

    Article  CAS  Google Scholar 

  3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.

    Article  CAS  Google Scholar 

  4. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N. Eng. J. Med. 2009;356:213–5.

    Article  Google Scholar 

  5. Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran, Iran. Diabetologia. 2009;52:1520–7.

    Article  CAS  Google Scholar 

  6. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31:96–8.

    Article  Google Scholar 

  7. Rasolabadi M, Khaledi S, Ardalan M, Kalhor MM, Penjvini S, Gharib A. Diabetes research in Iran: a scientometric analysis of publications output. Acta Informatica. Medica. 2015;23:160.

    Google Scholar 

  8. El-Mesallamy H, Suwailem S, Hamdy N. Evaluation of C-reactive protein, endothelin-1, adhesion molecule (s), and lipids as inflammatory markers in type 2 diabetes mellitus patients. Mediat Inflamm. 2007;2007:73635.

    Article  Google Scholar 

  9. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. New Engl J Med. 1993;329:1988–92.

    Article  CAS  Google Scholar 

  10. Bohl M, Bjørnshave A, Larsen M, Gregersen S, Hermansen K. The effects of proteins and medium-chain fatty acids from milk on body composition, insulin sensitivity and blood pressure in abdominally obese adults. Eur J Clin Nutr. 2017;71:76.

    Article  CAS  Google Scholar 

  11. van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediat Inflamm. 2010;2010:792393.

    Google Scholar 

  12. Goh S-Y, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93:1143–52.

    Article  CAS  Google Scholar 

  13. Lapolla A, Piarulli F, Sartore G, Ceriello A, Ragazzi E, Reitano R, et al. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care. 2007;30:670–6.

    Article  CAS  Google Scholar 

  14. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94:3171–82.

    Article  CAS  Google Scholar 

  15. Eschen O, Christensen JH, Toft E, Schmidt EB. Soluble adhesion molecules and marine n-3 fatty acids in patients referred for coronary angiography. Atherosclerosis. 2005;180:327–31.

    Article  CAS  Google Scholar 

  16. Dugoua J-J, Seely D, Perri D, Cooley K, Forelli T, Mills E, et al. From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol. 2007;85:837–47.

    Article  CAS  Google Scholar 

  17. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002;25:608–13.

    Article  Google Scholar 

  18. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26:1277–94.

    Article  CAS  Google Scholar 

  19. Peng X, Cheng K-W, Ma J, Chen B, Ho C-T, Lo C, et al. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem. 2008;56:1907–11.

    Article  CAS  Google Scholar 

  20. Sheikh N, Safari M, Araghchian M, Zeraati F. The effect of somac, cinnamomun and black pepper on albumin glycation in-vitro. J Med Plants. 2003;3:13–8.

    Google Scholar 

  21. Mashhadi NS, Ghiasvand R, Askari G, Feizi A, Hariri M, Darvishi L, et al. Influence of ginger and cinnamon intake on inflammation and muscle soreness endued by exercise in Iranian female athletes. Int J Prev Med. 2013;4:S11.

    PubMed  PubMed Central  Google Scholar 

  22. Mashhadi NS, Ghiasvand R, Hariri M, Askari G, Feizi A, Darvishi L, et al. Effect of ginger and cinnamon intake on oxidative stress and exercise performance and body composition in Iranian female athletes. Int J Prev Med. 2013;4:S31.

    PubMed  PubMed Central  Google Scholar 

  23. Hong J-W, Yang G-E, Kim YB, Eom SH, Lew J-H, Kang H. Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complement Altern Med. 2012;12:237.

    Article  Google Scholar 

  24. Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006;136:977–80.

    Article  CAS  Google Scholar 

  25. Talaei B, Amouzegar A, Sahranavard S, Hedayati M, Mirmiran P, Azizi F. Effects of cinnamon consumption on glycemic indicators, advanced glycation end products, and antioxidant status in type 2 diabetic patients. Nutrients. 2017;9:991.

    Article  Google Scholar 

  26. Yamagishi S-i, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta. 2012;1820:663–71.

    Article  CAS  Google Scholar 

  27. Pourvali K, Abbasi M, Mottaghi A. Role of superoxide dismutase 2 gene Ala16Val polymorphism and total antioxidant capacity in diabetes and its complications. Avicenna J Med Biotechnol. 2016;8:48.

    PubMed  PubMed Central  Google Scholar 

  28. Moselhy SS, Ali HK. Hepatoprotective effect of cinnamon extracts against carbon tetrachloride induced oxidative stress and liver injury in rats. Biol Res. 2009;42:93–8.

    Article  Google Scholar 

  29. Amin KA, El-Twab TMA. Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon. Int J Clin Exp Med. 2009;2:254.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys. 2007;459:214–22.

    Article  CAS  Google Scholar 

  31. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care. 2013;36:845–53.

    Article  CAS  Google Scholar 

  32. Dakhale GN, Chaudhari HV, Shrivastava M. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci. 2011;2011:195271.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to gratitude the Research Institute for Endocrine Science, Shahid Beheshti University of Medical Science, Tehran, Iran, for financial support of this study. And special thanks to the participants for their cooperation.

Author information

Author notes

  1. These authors contributed equally: Parvin Mirmiran, Mina Davari, Reza Hashemi

Authors and Affiliations

  1. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Parvin Mirmiran

  2. Nutrition Research Center, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran

    Mina Davari & Reza Hashemi

  3. Cellular & Molecular Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mehdi Hedayati

  4. Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Shamim Sahranavard

  5. Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Shohreh Bahreini

  6. Department of Nutrition, School of Health, Kerman University of Medical Sciences, Kerman, Iran

    Rahele Tavakoly

  7. Student Research Committee, School of Health, Kerman University of Medical Sciences, Kerman, Iran

    Rahele Tavakoly

  8. Department of Nutrition, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran

    Behrouz Talaei

  9. Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran

    Behrouz Talaei

Authors
  1. Parvin Mirmiran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mina Davari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reza Hashemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehdi Hedayati
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shamim Sahranavard
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shohreh Bahreini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rahele Tavakoly
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Behrouz Talaei
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BT, PM, and MH have designed and supervised the project, BT, SS. RT, and SB have contributed in data collection, conception, and statistical analysis. BT and MD have written the first draft of the paper. RH completed the revised paper and drew the figures by graph pad prism. All authors have done their duty under the supervision of PM as the main author. Also, all authors approved the final version of the paper.

Corresponding author

Correspondence to Behrouz Talaei.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mirmiran, P., Davari, M., Hashemi, R. et al. A randomized controlled trial to determining the effect of cinnamon on the plasma levels of soluble forms of vascular adhesion molecules in type 2 diabetes mellitus. Eur J Clin Nutr 73, 1605–1612 (2019). https://doi.org/10.1038/s41430-019-0523-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41430-019-0523-9

This article is cited by

Search

Advanced search

Quick links